UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058337
Receipt number R000066691
Scientific Title Use of an all-in-one sphincterotome with high rotation performance and freely bendable blade for Endoscopic Retrograde Cholangio-Pancreatography
Date of disclosure of the study information 2025/07/31
Last modified on 2025/07/01 18:10:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Use of an all-in-one sphincterotome with high rotation performance and freely bendable blade for Endoscopic Retrograde Cholangio-Pancreatography

Acronym

Use of an all-in-one sphincterotome with high rotation performance and freely bendable blade for Endoscopic Retrograde Cholangio-Pancreatography

Scientific Title

Use of an all-in-one sphincterotome with high rotation performance and freely bendable blade for Endoscopic Retrograde Cholangio-Pancreatography

Scientific Title:Acronym

Use of an all-in-one sphincterotome with high rotation performance and freely bendable blade for Endoscopic Retrograde Cholangio-Pancreatography

Region

Japan


Condition

Condition

Billiary tract desease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to evaluate the clinical utility and optimal usage techniques of a newly developed all-in-one sphincterotome, released in May 2024, which offers superior rotational capability and a highly flexible tip, in ERCP-related procedures performed not only in patients with surgically altered anatomy but also in those with normal anatomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Success rate of EST and the success rate of bile duct cannulation in native papilla.

Key secondary outcomes

Incidence of complications and the success rate of cannulation as a secondary device.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

28 years-old <=

Age-upper limit

91 years-old >=

Gender

Male and Female

Key inclusion criteria

Patientin which ERCP-related procedures were performed using all-in-one sphincterotome at Dokkyo Medical University Hospital between November 2023 and December 2024.

Key exclusion criteria

Cases in which consent to participate in the study was withdrawn after disclosure of information and cases in which the researcher determined that the patient was not excluded for this study.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Yasuhito
Middle name
Last name Kunogi

Organization

Dokkyo medical university School of medicine

Division name

Department of Gastroenterology

Zip code

321-0293

Address

880, Kitakobayashi, Mibu, Shimotsuga, Tochigi

TEL

0282861111

Email

ykunogi@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Yasuhito
Middle name
Last name Kunogi

Organization

Dokkyo Medical University School of Medicine

Division name

Department of Gastroenterology

Zip code

321-0293

Address

880, Kitakobayashi, Mibu, Shimotsuga, Tochigi

TEL

0282861111

Homepage URL


Email

ykunogi@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University School of Medicine

Address

880, Kitakobayashi, Mibu, Shimotsuga, Tochigi

Tel

0282861111

Email

soumu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

108

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 11 Month 01 Day

Date of IRB

2024 Year 03 Month 22 Day

Anticipated trial start date

2023 Year 11 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study aims to evaluate the utility of an all-in-one sphincterotome in ERCP-related procedures.


Management information

Registered date

2025 Year 07 Month 01 Day

Last modified on

2025 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066691